← Leaderboards
Wei Zhang
Wake Forest University Health Sciences
$8,137,806
Attributed
$11,382,964
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $952.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,382,964 · 15
By mechanism
R01$8,929,791 · 5
P30$1,165,541 · 2
R21$776,560 · 2
R56$246,657 · 1
R03$155,000 · 1
R29$107,994 · 1
Top collaborators
- Gregory Neal Fuller12 shared
- Liang Liu7 shared
- Cristina Maria Furdui3 shared
- Stanley R Hamilton2 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Liang Liu$976,048
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMolecularBaseProgramsEventTumorAreaGenomicsMemberMutationResearch StudyComprehensive Cancer CenterReportingBaptist ChurchPathway InteractionsMouse ModelForestBiological ModelsMissionPublishingOncogenesCellsGliomaOncogenic
Grant awards (56)
Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies$555,768
R01 · FY2025 · CA · contact PI
Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies$527,981
R01 · FY2024 · CA · contact PI
Overcoming racial health disparities in lung cancer through innovative mechanism-based therapeutic strategies$555,770
R01 · FY2023 · CA · contact PI
Developing unbiased AI/Deep learning pipelines to strengthen lung cancer health disparities research$305,539
R01 · FY2023 · CA · contact PI
A novel role of mutant p53 in intronic polyadenylation and impairment of DNA repair$77,500
R03 · FY2023 · CA
A novel role of mutant p53 in intronic polyadenylation and impairment of DNA repair$77,500
R03 · FY2022 · CA
Bioinformatics Shared Resource$331,259
P30 · FY2021 · CA · contact PI
Cancer Genetics and Metabolism Program$38,066
P30 · FY2021 · CA · contact PI
Tumor microenvironment at single cell level in black and white NSCLC patients$398,545
R21 · FY2020 · CA · contact PI
Bioinformatics Shared Resource$329,372
P30 · FY2020 · CA · contact PI
Cancer Genetics and Metabolism Program$37,850
P30 · FY2020 · CA · contact PI
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma$299,193
R01 · FY2019 · CA · contact PI
Bioinformatics Shared Resource$202,379
P30 · FY2019 · CA · contact PI
Cancer Genetics and Metabolism Program$96,816
P30 · FY2019 · CA · contact PI
Bioinformatics Shared Resource$29,411
P30 · FY2019 · CA · contact PI
Cancer Genetics and Metabolism Program$29,410
P30 · FY2019 · CA · contact PI
Bioinformatics Shared Resource$14,690
P30 · FY2019 · CA · contact PI
Cancer Genetics and Metabolism Program$14,689
P30 · FY2019 · CA · contact PI
Bioinformatics Shared Resource$11,764
P30 · FY2019 · CA · contact PI
Cancer Genetics and Metabolism Program$11,763
P30 · FY2019 · CA · contact PI
Bioinformatics Shared Resource$5,639
P30 · FY2019 · CA · contact PI
Cancer Genetics and Metabolism Program$5,639
P30 · FY2019 · CA · contact PI
Bioinformatics Shared Resource$3,398
P30 · FY2019 · CA · contact PI
Cancer Genetics and Metabolism Program$3,396
P30 · FY2019 · CA · contact PI
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma$308,447
R01 · FY2018 · CA · contact PI
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma$142,550
R01 · FY2017 · CA · contact PI
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma$385,948
R01 · FY2016 · CA · contact PI
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma$12,450
R01 · FY2016 · CA · contact PI
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma$398,398
R01 · FY2015 · CA · contact PI
Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma$398,398
R01 · FY2014 · CA · contact PI
Oncogene cooperation in glioma genesis$308,475
R01 · FY2014 · CA · contact PI
Dissecting Glioma Genesis through a Glial-Specific Mouse Model$230,362
R01 · FY2014 · CA · contact PI
Dissecting Glioma Genesis through a Glial-Specific Mouse Model$14,889
R01 · FY2014 · CA · contact PI
Oncogene cooperation in glioma genesis$298,934
R01 · FY2013 · CA · contact PI
Dissecting Glioma Genesis through a Glial-Specific Mouse Model$237,667
R01 · FY2013 · CA · contact PI
Oncogene cooperation in glioma genesis$318,015
R01 · FY2012 · CA · contact PI
Dissecting Glioma Genesis through a Glial-Specific Mouse Model$252,836
R01 · FY2012 · CA · contact PI
Identification of microRNAs as blood-based markers for colorectal cancer$171,825
R21 · FY2012 · CA · contact PI
Oncogene cooperation in glioma genesis$318,015
R01 · FY2011 · CA · contact PI
Dissecting Glioma Genesis through a Glial-Specific Mouse Model$252,836
R01 · FY2011 · CA · contact PI
Identification of microRNAs as blood-based markers for colorectal cancer$206,190
R21 · FY2011 · CA · contact PI
Oncogene cooperation in glioma genesis$327,850
R01 · FY2010 · CA · contact PI
Dissecting Glioma Genesis through a Glial-Specific Mouse Model$260,656
R01 · FY2010 · CA · contact PI
Dissecting Glioma Genesis through a Glial-Specific Mouse Model$246,657
R56 · FY2009 · CA · contact PI
EXPLORING CD14-DEPENDENT ENDOTOXIN RECOGNITION MECHANISM$473
P41 · FY2008 · RR · contact PI
glioma Through Genomics and Transgenic Mouse Model$234,808
R01 · FY2007 · CA · contact PI
EXPLORING CD14-DEPENDENT ENDOTOXIN RECOGNITION MECHANISM$299
P41 · FY2007 · RR · contact PI
Characterization of Leiomyosarcoma and GIST by Genomics$295,272
R01 · FY2006 · CA · contact PI
glioma Through Genomics and Transgenic Mouse Model$241,820
R01 · FY2006 · CA · contact PI
Characterization of Leiomyosarcoma and GIST by Genomics$324,628
R01 · FY2005 · CA
glioma Through Genomics and Transgenic Mouse Model$247,640
R01 · FY2005 · CA
AZAPROLINE ON AMIDE CIS TRANS ISOMERISM CONFORMATIONAL ANALYSES &NMR$649
P41 · FY2005 · RR
Characterization of Leiomyosarcoma and GIST by Genomics$302,378
R01 · FY2004 · CA
glioma Through Genomics and Transgenic Mouse Model$247,640
R01 · FY2004 · CA
Characterization of Leiomyosarcoma and GIST by Genomics$324,628
R01 · FY2003 · CA
REGULATION OF TUMOR SUPPRESSOR P53 BY PHOSPHORYLATION$107,994
R29 · FY2000 · CA